You are here

Home » Content

Perikardiyal Efüzyonun Subksifoid Yaklaşım ile Tedavisi

Subxiphoid Approach for Treatment of Pericardial Effusion

Journal Name:

  • Fırat Tıp Dergisi

Publication Year:

  • 2004

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Objective: Forty-two patients with pericardial effusion admitted to our clinic between January 1996 - June 2002 were treated through subxiphoid pericardiotomy. Methods: 23 of patients were male and 19 were female and their ages were between 11 months to 82 years. The procedure was carried out with local anesthesia and sedation in 38 (90 %) patients and under general anesthesia in 4 patients. These 4 patients were not tolerated local anesthesia. Results: Uremia was most common cause of pericardial effusion. 13 patients with cardiac tamponade were underwent emergency operation. Average drainage volume was 980 ml in patients with uremia, 1040 ml in patients with malignant disease. Two patients were died postoperatively. Thirty-two patients (76.2 %) were followed up to 3 to 20 months, with a mean follow up period of 9±3.8 months. Recurrent pericardial effusion requiring repeated surgical intervention was observed in 4 patients (9.5 %). Conclusion: Subxiphoid drainage is the procedure of choice for patients with pericardial tamponade. Because, it can be performed quickly under local anesthesia, offers sufficient drainage, biopsy for histopathologic examination, associated with minimal mortality and morbidity and prevents recurrent tamponade. ©2004, Fırat Üniversitesi, Tıp Fakültesi
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Ocak 1996 ile Haziran 2002 tarihleri arasında subksifoid perikardiyotomi tekniği ile tedavi edilen 42 perikardiyal efüzyonlu hasta retrospektif incelendi. Yöntem: Hastaların 19'u bayan, 23'ü erkek olup yaşları 11 ay ile 82 yaş arasındaydı. Prosedür 38 hastada (% 90.0) lokal anestezi ve sedasyon altında gerçekleştirildi. Operasyona lokal anestezi ile başlanılan 4 hastada lokal anesteziyi tolere edememeleri nedeniyle genel anesteziye geçildi. Bulgular: Üremi 11 vaka ile (% 26.2) en sık perikardiyal efüzyon nedeniydi. Hastaların 13'ü, kardiyak tamponad tanısı ile acil operasyona alındı. Ortalama toplam drenaj üremik hastalarda 980 ml, maligniteli hastalarda 1040 ml idi. Postoperatif 2 hasta kaybedildi. Hastaların 32'si 3 ile 20 ay, ortalama 9±3.8 ay takip edildi. Rekürren efüzyon nedeniyle 4 hastada (% 9.5) yeniden subksifoid perikardiyotomi girişimi gerekti. Sonuç: Subksifoid perikardiyotomi, hızlı uygulanabilmesi, genel anestezi gerektirmemesi, yeterli drenaj ve biyopsi imkanı sağlaması, kabül edilebilir morbidite ve mortalite oranları nedeniyle perikardiyal efüzyon ve kardiyak tamponad tedavisinde ilk tercih edilmesi gereken yöntemdir. ©2004, Fırat Üniversitesi, Tıp Fakültesi
FULL TEXT (PDF): 
PDF icon arastirmax-perikardiyal-efuzyonun-subksifoid-yaklasim-ile-tedavisi.pdf
  • 1
6-10
  • Turkish

REFERENCES

References: 

1. Sarıgül A, Farsak B, Ateş MŞ. Subxiphoid approach for treatment of pericardial effusion. Asian Cardiovascular & Thoracic Annals
1999; 7:297-300
2. Nataf P, Cacoub P, Regan M, Baron F, Dorent R, Pavie A, Gandjbakhch I. Video-thoracoscopic pericardial window in the diagnosis and treatment of pericardial effusions. Am J Cardiol 1998;82:124-126
3. Edward PC, Miller JI. Modern approaches and use of surgical treatment for pericardial disease. Current Cardiology Reports
2002; 4:41-46
4. Hancock EW. Management of pericardial disease. Mod Concepts
Cardiovasc Dis 1979; 48:1-6
5. Wong B, Murphy J, Chang CJ, Hassenein K, Dunn M. The risk of pericardiocentesis. Am J Cardiol 1979; 44:1110-14
6. Markievicz W, Borovik R, Ecker S. Cardiac tamponade in medical patients: treatment and prognosis in the echocardiographic era. Am Heart J 1986; 111:1138-42
7. Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons
M. Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart 1996; 75:67-71
8. Fontenelle LJ, Cuello L, Dooley BN. Subxiphoid pericardial window. Am J Surg 1970; 120:679-809. Moores DW, Allen KB, Faber LP, Dziuban SW, Gillman DJ,
Warren WH, et al. Subxiphoid pericardial drainage for pericardial tamponade. J Thorac Cardiovasc Surg 1995; 109:546-51
10. Little AG, Kremser PC, Wade JL, Levett JM, DeMeester TR,
Skinner DB. Operation for diagnosis and treatment of pericardial effusions. Surgery 1984; 96:738-44
11. Mueller XM, Tevaearai HT, Hurni M, Ruchat P, Fischer AP, Stumpe F, von Segesser LK. Long-term results of surgical subxiphoid pericardial drainage. Thorac Cardiovasc Surg 1997;
45:65-69
12. Naunheim KS, Kesler KA, Fiore AC, Turrentine M, Hammell LM, Brown JW, et al. Pericardial drainage: subxiphoid vs. transthoracic approach. Eur J Cardiothorac Surg 1991; 5:99-103
13. Sugimoto JT, Little AG, Ferguson MK, Borow KM, Vallera D,
Staszak VM, Weinert L. Pericardial window: mechanisms of
efficacy. Ann Thorac Surg 1990; 50:442-445
14. Palacios IF, Tuzcu EM, Ziskind AA, Younger J, Block PC.
Percutaneous balloon pericardial window for patients with malignant pericardial effusion and tamponade. Cathet Cardiovasc
Diagn 1991; 22:244-249
15. Law DA, Haque R, Jain A. Percutaneous balloon pericardiotomy: non-surgical treatment for patients with cardiac tamponade. WV
Med J 1997; 93:310-312

Thank you for copying data from http://www.arastirmax.com